Highlighted Study: Verification of FDA-Cleared Kappa and Lambda Free Light Chain Assays on the Beckman Coulter DxC 800

Highlighted Study: Verification of FDA-Cleared Kappa and Lambda Free Light Chain Assays on the Beckman Coulter DxC 800

SAN DIEGO, CA – (November 14, 2019) In a newly published study, Diazyme’s Kappa and Lambda Free Light Chain Assay performance was verified on the Beckman Coulter DxC 800.

“We conclude the Diazyme κ and λ FLC assays when run on the Beckman-Coulter DxC analyzer exhibit excellent precision and accuracy, and are comparable to the Freelite assays on the Roche Cobas Integra analyzer”.

Click below to read the full article
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform